[{"evidenceId":12728,"evidenceType":"GENE_BACKGROUND","shortDesc":null,"desc":"The DNMT3A gene encodes a de novo DNA methyltransferase that is responsible for establishing de novo genomic DNA methylation patterns. It functions in concert with another de novo methyltransferase, DNMT3B, and a maintenance methyltransferase DNMT1, assisted by non-catalytic subunit DNMT3L (PMID: 21243710). CpG methylation is important for maintaining epigenetic tissue-type-specific gene expression patterns, genomic imprinting, X-chromosome inactivation, silencing of parasitic DNA sequences and genome integrity (PMID: 12359337, 15215868). Unlike loss of DNMT1 and DNMT3B, DNMT3A knock-out mice develop to term and die around 3-4 weeks after birth due to failure to thrive (PMID: 10555141). DNMT3A is mutated in Tatton-Brown-Rahman overgrowth syndrome with intellectual disability (PMID: 24614070), and overexpression has been linked to melanoma and hepatocellular carcinoma (PMID: 24589714). DNMT3A is recurrently mutated in de novo acute myeloid leukemia (AML) (up to 30% of all cases) (PMID: 21067377, 21399634, 22417203, 23634996), and at lower frequencies in secondary acute myeloid leukemia (PMID: 21993668), myeloproliferative neoplasms (PMID: 21537334), myelodysplastic syndromes (PMID: 21415852, 21519343) and in T-cell acute lymphoblastic leukemia (T-ALL) (PMID: 23341344, 23603912, 23687089).","id":null,"lastEdit":"2017-04-13","status":null,"gene":{"entrezGeneId":1788,"hugoSymbol":"DNMT3A","name":"DNA methyltransferase 3 alpha","oncogene":false,"curatedIsoform":"ENST00000264709","curatedRefSeq":"NM_022552.4","geneAliases":["DNMT3A2","TBRS","M.HsaIIIA"],"tsg":true},"articles":[{"pmid":"23634996","title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.","journal":"The New England journal of medicine","pubDate":"2013 May 30","volume":"368","issue":"22","pages":"2059-74","authors":"Cancer Genome Atlas Research Network. et al","elocationId":"doi: 10.1056/NEJMoa1301689","link":null,"reference":"Cancer Genome Atlas Research Network. et al. The New England journal of medicine. 2013 May 30;368(22)2059-74.","abstract":null},{"pmid":"21067377","title":"DNMT3A mutations in acute myeloid leukemia.","journal":"The New England journal of medicine","pubDate":"2010 Dec 16","volume":"363","issue":"25","pages":"2424-33","authors":"Ley TJ et al","elocationId":"doi: 10.1056/NEJMoa1005143","link":null,"reference":"Ley TJ et al. The New England journal of medicine. 2010 Dec 16;363(25)2424-33.","abstract":null},{"pmid":"21993668","title":"Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia.","journal":"Haematologica","pubDate":"2012 Feb","volume":"97","issue":"2","pages":"246-50","authors":"Fried I et al","elocationId":"doi: 10.3324/haematol.2011.051581","link":null,"reference":"Fried I et al. Haematologica. 2012 Feb;97(2)246-50.","abstract":null},{"pmid":"10555141","title":"DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.","journal":"Cell","pubDate":"1999 Oct 29","volume":"99","issue":"3","pages":"247-57","authors":"Okano M et al","elocationId":"","link":null,"reference":"Okano M et al. Cell. 1999 Oct 29;99(3)247-57.","abstract":null},{"pmid":"15215868","title":"Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting.","journal":"Nature","pubDate":"2004 Jun 24","volume":"429","issue":"6994","pages":"900-3","authors":"Kaneda M et al","elocationId":"","link":null,"reference":"Kaneda M et al. Nature. 2004 Jun 24;429(6994)900-3.","abstract":null},{"pmid":"23687089","title":"Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia.","journal":"Blood","pubDate":"2013 Jul 4","volume":"122","issue":"1","pages":"74-82","authors":"Van Vlierberghe P et al","elocationId":"doi: 10.1182/blood-2013-03-491092","link":null,"reference":"Van Vlierberghe P et al. Blood. 2013 Jul 4;122(1)74-82.","abstract":null},{"pmid":"21415852","title":"Recurrent DNMT3A mutations in patients with myelodysplastic syndromes.","journal":"Leukemia","pubDate":"2011 Jul","volume":"25","issue":"7","pages":"1153-8","authors":"Walter MJ et al","elocationId":"doi: 10.1038/leu.2011.44","link":null,"reference":"Walter MJ et al. Leukemia. 2011 Jul;25(7)1153-8.","abstract":null},{"pmid":"21519343","title":"DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms.","journal":"Leukemia","pubDate":"2011 Jul","volume":"25","issue":"7","pages":"1219-20","authors":"Abdel-Wahab O et al","elocationId":"doi: 10.1038/leu.2011.82","link":null,"reference":"Abdel-Wahab O et al. Leukemia. 2011 Jul;25(7)1219-20.","abstract":null},{"pmid":"24589714","title":"The de novo DNA methyltransferase DNMT3A in development and cancer.","journal":"Epigenetics","pubDate":"2014 May","volume":"9","issue":"5","pages":"669-77","authors":"Chen BF et al","elocationId":"doi: 10.4161/epi.28324","link":null,"reference":"Chen BF et al. Epigenetics. 2014 May;9(5)669-77.","abstract":null},{"pmid":"24614070","title":"Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability.","journal":"Nature genetics","pubDate":"2014 Apr","volume":"46","issue":"4","pages":"385-8","authors":"Tatton-Brown K et al","elocationId":"doi: 10.1038/ng.2917","link":null,"reference":"Tatton-Brown K et al. Nature genetics. 2014 Apr;46(4)385-8.","abstract":null},{"pmid":"21399634","title":"Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia.","journal":"Nature genetics","pubDate":"2011 Mar 13","volume":"43","issue":"4","pages":"309-15","authors":"Yan XJ et al","elocationId":"doi: 10.1038/ng.788","link":null,"reference":"Yan XJ et al. Nature genetics. 2011 Mar 13;43(4)309-15.","abstract":null},{"pmid":"21243710","title":"Structure and function of mammalian DNA methyltransferases.","journal":"Chembiochem : a European journal of chemical biology","pubDate":"2011 Jan 24","volume":"12","issue":"2","pages":"206-22","authors":"Jurkowska RZ et al","elocationId":"doi: 10.1002/cbic.201000195","link":null,"reference":"Jurkowska RZ et al. Chembiochem : a European journal of chemical biology. 2011 Jan 24;12(2)206-22.","abstract":null},{"pmid":"22417203","title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.","journal":"The New England journal of medicine","pubDate":"2012 Mar 22","volume":"366","issue":"12","pages":"1079-89","authors":"Patel JP et al","elocationId":"doi: 10.1056/NEJMoa1112304","link":null,"reference":"Patel JP et al. The New England journal of medicine. 2012 Mar 22;366(12)1079-89.","abstract":null},{"pmid":"21537334","title":"DNMT3A mutations in myeloproliferative neoplasms.","journal":"Leukemia","pubDate":"2011 Jul","volume":"25","issue":"7","pages":"1217-9","authors":"Stegelmann F et al","elocationId":"doi: 10.1038/leu.2011.77","link":null,"reference":"Stegelmann F et al. Leukemia. 2011 Jul;25(7)1217-9.","abstract":null},{"pmid":"23341344","title":"The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.","journal":"Genes, chromosomes &amp; cancer","pubDate":"2013 Apr","volume":"52","issue":"4","pages":"410-22","authors":"Grossmann V et al","elocationId":"doi: 10.1002/gcc.22039","link":null,"reference":"Grossmann V et al. Genes, chromosomes &amp; cancer. 2013 Apr;52(4)410-22.","abstract":null},{"pmid":"12359337","title":"The human DNA methyltransferases DNMT3A and DNMT3B have two types of promoters with different CpG contents.","journal":"Biochimica et biophysica acta","pubDate":"2002 Sep 27","volume":"1577","issue":"3","pages":"457-65","authors":"Yanagisawa Y et al","elocationId":"","link":null,"reference":"Yanagisawa Y et al. Biochimica et biophysica acta. 2002 Sep 27;1577(3)457-65.","abstract":null},{"pmid":"23603912","title":"Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations.","journal":"Blood","pubDate":"2013 Jun 6","volume":"121","issue":"23","pages":"4749-52","authors":"Neumann M et al","elocationId":"doi: 10.1182/blood-2012-11-465138","link":null,"reference":"Neumann M et al. Blood. 2013 Jun 6;121(23)4749-52.","abstract":null}]},{"evidenceId":12727,"evidenceType":"GENE_SUMMARY","shortDesc":null,"desc":"DNMT3A encodes a DNA methyltransferase involved in embryonic development, imprinting and X chromosome inactivation. DNMT3A is recurrentlly mutated in acute myeloid leukemia, and mutated less frequently in a diverse range of cancers.","id":null,"lastEdit":"2017-04-13","status":null,"gene":{"entrezGeneId":1788,"hugoSymbol":"DNMT3A","name":"DNA methyltransferase 3 alpha","oncogene":false,"curatedIsoform":"ENST00000264709","curatedRefSeq":"NM_022552.4","geneAliases":["DNMT3A2","TBRS","M.HsaIIIA"],"tsg":true},"articles":[]}]